Second Sight Medical (EYES) IPO Opens Sharply Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- US stocks set for lower open as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- Goldman Sachs to acquire real estate company LCN for up to $410M
Second Sight Medical (EYES) Sees Profit Taking after 162% Post-IPO Surge
November 21, 2014 10:25 AM ESTThis week's hot IPO for Second Sight Medical (NASDAQ: EYES) is giving some back today. After gaining 162% in it fist two days of trading, shares are down 9.5% to $21.35 today. The IPO priced at $9.
Second Sight develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients
... MoreSecond Sight Medical (EYES) Momentum Continues Following Robust IPO
November 20, 2014 8:44 AM ESTSecond Sight Medical (NASDAQ: EYES) is showing early gains Thursday following the company's strong debut on yesterday's session.
Wednesday, Second Sight opened for trading at $17 after pricing 3.5 million common shares at $9 apiece. Overall, the stock close 122 percent higher to $19.97.
Ahead of the bell, Second Sight is up an additional 15 percent.
... MoreSecond Sight Medical (EYES) Picks Up Chatter Ahead of CNBC Coverage
November 19, 2014 12:50 PM ESTWhile off the highs, traders are getting chatty about today's IPO for Second Sight Medical Products (NASDAQ: EYES) as it is expected to be highlighted on CNBC in a little while. Shares are up 105% at last check to $18.50 after pricing at $9.
... MoreSecond Sight Medical Products (EYES) Prices 3.5M Common IPO at $9/Share
November 19, 2014 7:56 AM ESTSecond Sight Medical Products, Inc. (Nasdaq: EYES) announced the pricing of its initial public offering of 3,500,000 shares of common stock, at a price of $9.00 per share. Second Sight develops, manufactures and markets implantable visual prosthetics to restore some functional vision to blind patients. Its current product, the Argus® II System, which treats outer retinal degenerations such as retinitis... More
